Publications (100) Juan Carlos Pastrana Delgado publications

2024

  1. Seronegative autoimmune hepatitis

    Medicina (Buenos Aires), Vol. 84, Núm. 3, pp. 534-543

2023

  1. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

  2. Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort

    Frontiers in Endocrinology, Vol. 13

2022

  1. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 399, Núm. 10320, pp. 143-151

  2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    The Lancet, Vol. 400, Núm. 10349, pp. 359-368

  3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 399, Núm. 10325, pp. 665-676

  4. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

    Journal of Clinical Medicine, Vol. 11, Núm. 17

2021

  1. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the “Seguimiento Universidad de Navarra” (SUN) cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1728-1737

  2. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

  3. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    The Lancet, Vol. 397, Núm. 10289, pp. 2049-2059

  4. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    The Lancet, Vol. 397, Núm. 10285, pp. 1637-1645

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

2017

  1. Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort

    International Journal of Stroke, Vol. 12, Núm. 2, pp. 187-191

2016

  1. Are all metabolically healthy individuals with obesity at the same risk of diabetes onset?

    Obesity, Vol. 24, Núm. 12, pp. 2615-2623

  2. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort

    Journal of Hypertension, Vol. 34, Núm. 7, pp. 1257-1265

  3. The TyG index may predict the development of cardiovascular events

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 189-197

  4. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort

    Preventive Medicine, Vol. 86, pp. 99-105

  5. TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain

    Medicine (United States), Vol. 95, Núm. 19

2013

  1. Alteraciones de la hemostasia

    Fisiopatología y patología general básicas para ciencias de la salud (Elsevier), pp. 85-90

  2. Alteraciones de las plaquetas

    Fisiopatología y patología general básicas para ciencias de la salud (Elsevier), pp. 76-78